ヘリオスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2018/07/18 | 1,466 | 1,523 | 1,461 | 1,520 | +46 | +3.1% | 37,500 |
| 2018/07/17 | 1,488 | 1,488 | 1,461 | 1,474 | -4 | -0.3% | 35,300 |
| 2018/07/13 | 1,524 | 1,525 | 1,476 | 1,478 | -39 | -2.6% | 69,800 |
| 2018/07/12 | 1,509 | 1,534 | 1,509 | 1,517 | +5 | +0.3% | 28,300 |
| 2018/07/11 | 1,530 | 1,538 | 1,511 | 1,512 | -17 | -1.1% | 64,600 |
| 2018/07/10 | 1,550 | 1,552 | 1,529 | 1,529 | -16 | -1% | 34,900 |
| 2018/07/09 | 1,500 | 1,567 | 1,500 | 1,545 | +33 | +2.2% | 49,800 |
| 2018/07/06 | 1,499 | 1,512 | 1,456 | 1,512 | +13 | +0.9% | 60,500 |
| 2018/07/05 | 1,477 | 1,505 | 1,451 | 1,499 | ±0 | ±0% | 67,900 |
| 2018/07/04 | 1,491 | 1,512 | 1,465 | 1,499 | +1 | +0.1% | 45,200 |
| 2018/07/03 | 1,555 | 1,561 | 1,470 | 1,498 | -55 | -3.5% | 108,400 |
| 2018/07/02 | 1,624 | 1,624 | 1,551 | 1,553 | -62 | -3.8% | 55,200 |
| 2018/06/29 | 1,609 | 1,623 | 1,541 | 1,615 | +6 | +0.4% | 48,700 |
| 2018/06/28 | 1,526 | 1,609 | 1,526 | 1,609 | +3 | +0.2% | 97,800 |
| 2018/06/27 | 1,564 | 1,614 | 1,564 | 1,606 | +36 | +2.3% | 39,900 |
| 2018/06/26 | 1,535 | 1,575 | 1,516 | 1,570 | +10 | +0.6% | 104,000 |
| 2018/06/25 | 1,606 | 1,613 | 1,552 | 1,560 | -41 | -2.6% | 95,000 |
| 2018/06/22 | 1,628 | 1,634 | 1,600 | 1,601 | -39 | -2.4% | 28,600 |
| 2018/06/21 | 1,600 | 1,650 | 1,600 | 1,640 | +32 | +2% | 47,500 |
| 2018/06/20 | 1,660 | 1,660 | 1,566 | 1,608 | -53 | -3.2% | 148,200 |
| 2018/06/19 | 1,705 | 1,723 | 1,647 | 1,661 | -65 | -3.8% | 72,900 |
| 2018/06/18 | 1,775 | 1,790 | 1,723 | 1,726 | -26 | -1.5% | 84,900 |
| 2018/06/15 | 1,738 | 1,771 | 1,732 | 1,752 | +19 | +1.1% | 82,500 |
| 2018/06/14 | 1,740 | 1,758 | 1,715 | 1,733 | -31 | -1.8% | 73,100 |
| 2018/06/13 | 1,775 | 1,775 | 1,719 | 1,764 | +2 | +0.1% | 70,100 |
| 2018/06/12 | 1,705 | 1,772 | 1,700 | 1,762 | +62 | +3.6% | 139,100 |
| 2018/06/11 | 1,670 | 1,710 | 1,652 | 1,700 | +30 | +1.8% | 88,200 |
| 2018/06/08 | 1,639 | 1,678 | 1,619 | 1,670 | +66 | +4.1% | 103,700 |
| 2018/06/07 | 1,597 | 1,621 | 1,582 | 1,604 | +16 | +1% | 79,000 |
| 2018/06/06 | 1,600 | 1,618 | 1,561 | 1,588 | -19 | -1.2% | 102,300 |
| 2018/06/05 | 1,662 | 1,664 | 1,597 | 1,607 | -58 | -3.5% | 80,600 |
| 2018/06/04 | 1,660 | 1,674 | 1,639 | 1,665 | +11 | +0.7% | 67,500 |
| 2018/06/01 | 1,654 | 1,678 | 1,634 | 1,654 | -1 | -0.1% | 69,200 |
| 2018/05/31 | 1,680 | 1,687 | 1,607 | 1,655 | +15 | +0.9% | 101,300 |
| 2018/05/30 | 1,562 | 1,642 | 1,545 | 1,640 | +73 | +4.7% | 96,900 |
| 2018/05/29 | 1,591 | 1,600 | 1,563 | 1,567 | -34 | -2.1% | 68,400 |
| 2018/05/28 | 1,625 | 1,642 | 1,593 | 1,601 | -25 | -1.5% | 66,900 |
| 2018/05/25 | 1,650 | 1,719 | 1,617 | 1,626 | -7 | -0.4% | 169,900 |
| 2018/05/24 | 1,652 | 1,675 | 1,616 | 1,633 | -17 | -1% | 90,400 |
| 2018/05/23 | 1,687 | 1,687 | 1,642 | 1,650 | -23 | -1.4% | 77,300 |
| 2018/05/22 | 1,685 | 1,696 | 1,657 | 1,673 | -3 | -0.2% | 53,500 |
| 2018/05/21 | 1,680 | 1,693 | 1,668 | 1,676 | -9 | -0.5% | 47,900 |
| 2018/05/18 | 1,689 | 1,708 | 1,652 | 1,685 | -3 | -0.2% | 89,400 |
| 2018/05/17 | 1,737 | 1,769 | 1,666 | 1,688 | -2 | -0.1% | 141,400 |
| 2018/05/16 | 1,667 | 1,694 | 1,660 | 1,690 | +23 | +1.4% | 38,900 |
| 2018/05/15 | 1,653 | 1,669 | 1,644 | 1,667 | +12 | +0.7% | 31,500 |
| 2018/05/14 | 1,681 | 1,684 | 1,642 | 1,655 | -16 | -1% | 52,600 |
| 2018/05/11 | 1,670 | 1,706 | 1,631 | 1,671 | -6 | -0.4% | 82,300 |
| 2018/05/10 | 1,712 | 1,730 | 1,670 | 1,677 | -59 | -3.4% | 101,600 |
| 2018/05/09 | 1,795 | 1,795 | 1,699 | 1,736 | -80 | -4.4% | 165,300 |
1551～
1600
件表示中 / 2309件
類似銘柄と比較する
現在ご覧いただいている「ヘリオス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ヘリオス | 19,600円 | +395.9% | - | 0.00% | - | 5.45倍 |
|
ｉＰＳ細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
| ステムリム | 35,800円 | - | - | 0.00% | - | 2.91倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
| 大幸薬品 | 36,400円 | +11.1% | - | 0.00% | 33.21倍 | 2.26倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。不振の「クレベリン」など事業再構築中 |
| オンコリス | 70,300円 | +58.7% | - | 0.00% | - | 12.39倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
| Ｃｈｏｒｄｉａ | 24,900円 | - | - | 0.00% | - | 4.08倍 |
|
ＲＮＡ制御ストレスを標的とする低分子抗がん薬を開発中。開発品・研究者は武田にルーツ |
市場注目の銘柄
チャート関連のコラム
